ArticleCancer medicine2024

The Combined Inhibition of SREBP and mTORC1 Signaling Synergistically Inhibits B-Cell Lymphoma.

Zhenhan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.